Medicare Enrolled

Dr. Cornelius Robens, M.D.

Optician · Traverse City, MI
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
4100 PARK FOREST DR STE 200, Traverse City, MI 49684
2316007466
Registered in NPPES since 2005
NPI: 1538158688 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Robens from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Robens? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Robens

Dr. Cornelius Robens is an optician specialist in Traverse City, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Robens performed 5,406 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Robens received a total of $217,882 from 43 pharmaceutical and/or device companies across 583 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Robens is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 6% volume in MI $217,882 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
5,406
Medicare services
Top 6% in MI for optician
Not available
Unique patients (not deduplicated)
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
4,645 $5 $8
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
500 $72 $156
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
85 $55 $101
New patient office visit, complex (60-74 min) 40 $114 $277
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
36 $92 $228
Brain stimulator programming, first 15 minutes
Electronic analysis of an implanted brain, spinal cord, or peripheral neurostimulator generator. This service includes programming the brain stimulator by a qualified health professional for the first 15 minutes.
31 $35 $73
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 20 $25 $111
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
19 $61 $129
Electronic analysis of implanted neurostimulator
Electronic evaluation of an implanted brain, spinal cord, or peripheral nerve stimulator device.
16 $12 $28
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
14 $134 $307
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$217,882
Total received (2018-2024)
Avg $31,126/year across 7 years
Top 1% in MI for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
583
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$28,600
2023
$14,502
2022
$44,049
2021
$40,575
2020
$16,256
2019
$35,203
2018
$38,698

Payments by company (2024)

Teva Pharmaceuticals USA, Inc.
$17,671
ABBVIE INC.
$8,735
ARGENX US, INC.
$1,425
EMD Serono, Inc.
$137
UCB, Inc.
$90
Lilly USA, LLC
$82
Novartis Pharmaceuticals Corporation
$63
Abbott Laboratories
$62
Ipsen Biopharmaceuticals, Inc
$54
CATALYST PHARMACEUTICALS, INC.
$45
Eisai Inc.
$44
GE HEALTHCARE
$33
Neurelis, Inc.
$30
Kyowa Kirin, Inc.
$25
Biogen, Inc.
$21
Amneal Pharmaceuticals LLC
$21
MDD US Operations, LLC
$20
Boston Scientific Corporation
$17
Otsuka America Pharmaceutical, Inc.
$14
Celgene Corporation
$14
Top 3 companies account for 97.3% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$74,038
EMD Serono, Inc.
$28,568
GENZYME CORPORATION
$26,935
ABBVIE INC.
$26,655
Biogen, Inc.
$22,620
AbbVie Inc.
$15,874
Kyowa Kirin, Inc.
$7,906
Lundbeck LLC
$5,096
Acorda Therapeutics, Inc
$4,154
ARGENX US, INC.
$1,425
ACADIA Pharmaceuticals Inc
$1,174
Allergan, Inc.
$895
Allergan Inc.
$436
Abbott Laboratories
$358
Lilly USA, LLC
$196
E.R. Squibb & Sons, L.L.C.
$143
AbbVie, Inc.
$134
US WorldMeds, LLC
$122
LivaNova USA, Inc.
$110
UCB, Inc.
$106
Celgene Corporation
$98
Boston Scientific Corporation
$88
Novartis Pharmaceuticals Corporation
$78
Genentech, Inc.
$71
Ipsen Biopharmaceuticals, Inc
$69
Amgen Inc.
$65
Supernus Pharmaceuticals, Inc.
$64
CATALYST PHARMACEUTICALS, INC.
$45
Eisai Inc.
$44
Neurocrine Biosciences, Inc.
$36
Adamas Pharmaceuticals, Inc.
$34
GE HEALTHCARE
$33
Neurelis, Inc.
$30
Genentech USA, Inc.
$24
Janssen Pharmaceuticals, Inc
$23
Amneal Pharmaceuticals LLC
$21
Alexion Pharmaceuticals, Inc.
$20
MDD US Operations, LLC
$20
Mitsubishi Tanabe Pharma America, Inc.
$19
Impax Laboratories, Inc.
$15
Avanir Pharmaceuticals, Inc.
$15
Otsuka America Pharmaceutical, Inc.
$14
Sunovion Pharmaceuticals Inc.
$11
Top 3 companies account for 59.5% of all-time payments
Associated products mentioned in payments ›
AJOVY · AMYVID · APOKYN · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Apokyn · Austedo XR · BOTOX · BOTOX THERAPEUTIC · Briviact · COPAXONE · DUOPA · Duopa · Dysport · EMGALITY · FYCOMPA · GENERAL DBS · GOCOVRI · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · Leqembi · Mavenclad · NORTHERA · NOURIANZ · NUPLAZID · Nourianz · Nuedexta · OCREVUS · ONGENTYS · OXTELLAR XR · PLEGRIDY · PROCLAIM · QULIPTA · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPRAVATO · TECFIDERA · TROKENDI XR · TYSABRI · UBRELVY · VALTOCO · VERCISE · VNS - Sentiva · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Xadago · ZEPOSIA · ZINBRYTA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an optician specialist in Traverse City?
Compare opticians in the Traverse City area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians in nearby ZIP areas
8
County median income
$91,943
Nearest hospital to ZIP centroid (approximate)
MUNSON MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Robens is a mixed practice specialist, with above-average Medicare volume (top 6% in MI), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Robens experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Robens performed 4,645 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Robens receive payments from pharmaceutical companies?
Yes. Dr. Robens received a total of $217,882 from 43 companies across 583 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Robens's costs compare to other opticians in Traverse City?
Dr. Robens's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Robens) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →